Skip to main content
All lobbying clients

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Lobbying client · Connecticut · filed 2025 to 2026

Pharmaceutical company.

$910,000 Reported spend
22 Filings counted
4 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 22 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $390,000 9 filings
  • 2025 $520,000 13 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 21
  • SENATE 21
 Recent filings 22 total
Q3 report
ALB SOLUTIONS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View → Q3 report
THORN RUN PARTNERS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View → Q3 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 16, 2026
View → Q2 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View → Q2 report
THORN RUN PARTNERS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 19, 2026
View → Q2 report
ALB SOLUTIONS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 16, 2026
View → Q1 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 20, 2026
View → Q1 report
THORN RUN PARTNERS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 18, 2026
View → Q1 report
ALB SOLUTIONS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 15, 2026
View → Q4 report
THORN RUN PARTNERS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View → Q4 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 20, 2026
View → Q4 report
ALB SOLUTIONS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 18, 2026
View → Q3 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025
View → Q3 report
THORN RUN PARTNERS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View → Q3 report
ALB SOLUTIONS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025
View → Q2 report
THORN RUN PARTNERS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 16, 2025
View → Q2 report
ALB SOLUTIONS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 16, 2025
View → Q2 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 14, 2025
View → Q1 report
ALB SOLUTIONS
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 18, 2025
View → Q1 report
THORN RUN PARTNERS
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 16, 2025
View →

Showing the 20 most recent of 22 filings. Search the explorer for "BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem